C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Other companies in C4 Therapeutics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
C4 Therapeutics has a consensus price target of $10.82.
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $3.97 last updated December 20, 2024 at 7:31 PM EST.
There are no upcoming dividends for C4 Therapeutics.
C4 Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for C4 Therapeutics.
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.